Tools

LEADER 03249cam 2200529 a 4500

001 ocm40216284;

003 OCoLC;

005 20200727083709.0;

008 980821s1998 mdua b f000 0 eng d;

010 a| 98186785;

019 a| 39743478;

035 a| (Sirsi) o40216284;

035 a| (OCoLC)40216284;

042 a| lccopycat;

043 a| n-us---;

049 a| ERE#;

074 a| 0831-C-12;

074 a| 0831-C-12 (online);

086 0 a| HE 20.3965:176;

245 00 a| Cost-benefit/cost-effectiveness research of drug abuse prevention :b| implications for programming and policy /c| editors, William J. Bukoski, Richard I. Evans.;

260 a| Rockville, MD :b| U.S. Dept. of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, Division of Epidemiology and Prevention Research,c| 1998.;

300 a| iv, 233 pages :b| illustrations ;c| 24 cm.;

336 a| text2| rdacontent;

337 a| unmediated2| rdamedia;

338 a| volume2| rdacarrier;

490 1 a| NIH publication ;v| no. 98-4021;

490 1 a| NIDA research monograph ;v| 176;

500 a| "Based on the papers from a technical review ... held on July 28-29, 1994"--P. ii.;

504 a| Includes bibliographical references.;

505 0 a| Impact of substance abuse on federal spending -- Historical perspective on effective prevention -- School-based approaches to drug abuse prevention: evidence for effectiveness and suggestions for determining cost-effectiveness -- Effectiveness of prevention interventions with youth at high risk of drug abuse -- Costs, benefits, and cost-effectiveness of comprehensive drug abuse prevention -- Overview of methods: cost-effectiveness, cost-benefits, and cost-offsets of prevention -- Analytic issues for estimating the benefits and costs of substance abuse prevention -- Benefits and costs of a family-focused methadone treatment and drug abuse prevention program: preliminary findings -- Issues and methods in evaluating costs, benefits, and cost-effectiveness of drug abuse prevention programs for high-risk youth -- Implications for prevention policy: a commentary.;

530 a| Also available via Internet from NIDA web site. Address as of 7/21/04: http://165.112.78.61/pdf/monographs/monograph176/download176.html; current access available via PURL.;

650 0 a| Substance abusex| Prevention and controlz| United States.=| ^A317;

650 0 a| Substance abusex| Economicsz| United States.=| ^A317;

650 0 a| Cost effectiveness.=| ^A17117;

700 1 a| Bukoski, William J.=| ^A299984;

700 1 a| Evans, Richard I.q| (Richard Isadore),d| 1922-2015.=| ^A25674;

710 2 a| National Institute on Drug Abuse.b| Division of Epidemiology and Prevention Research.=| ^A368046;

830 0 a| NIDA research monographv| 176.=| ^A467532;

830 0 a| NIH publication ;v| no. 98-4021.=| ^A2592;

856 41 u| https://purl.fdlp.gov/GPO/LPS51794;

998 a| 966868;

998 a| u966868;

096 a| W 74 C837 1994;

596 a| 1;

999 a| HE 20.3965:176w| SUDOCc| 1i| 30372017420222d| 8/7/2007l| JDOSm| JOYNERr| Ys| Yt| JDOSBKu| 8/10/2004x| BOOKz| JFEDDOCSo| .STAFF. 0;

Cost-benefit/cost-effectiveness research of drug abuse prevention : implications for programming and policy / editors, William J. Bukoski, Richard I. Evans.

Other author	Bukoski, William J.
Other author	Evans, Richard I. (Richard Isadore), 1922-2015.
Other author	National Institute on Drug Abuse. Division of Epidemiology and Prevention Research.
Format	Book
Publication Info	Rockville, MD : U.S. Dept. of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, Division of Epidemiology and Prevention Research, 1998.
Description	iv, 233 pages : illustrations ; 24 cm.
Supplemental Content	https://purl.fdlp.gov/GPO/LPS51794
Subjects	Drug abuse--United States. --Prevention. --Finance. Substance abuse--Prevention and control. --United States. Substance abuse--Economics. --United States. Cost effectiveness.

Series	NIH publication ; no. 98-4021 NIDA research monograph ; 176 NIDA research monograph 176. ^A467532 NIH publication ; no. 98-4021. ^A2592
Contents	Impact of substance abuse on federal spending -- Historical perspective on effective prevention -- School-based approaches to drug abuse prevention: evidence for effectiveness and suggestions for determining cost-effectiveness -- Effectiveness of prevention interventions with youth at high risk of drug abuse -- Costs, benefits, and cost-effectiveness of comprehensive drug abuse prevention -- Overview of methods: cost-effectiveness, cost-benefits, and cost-offsets of prevention -- Analytic issues for estimating the benefits and costs of substance abuse prevention -- Benefits and costs of a family-focused methadone treatment and drug abuse prevention program: preliminary findings -- Issues and methods in evaluating costs, benefits, and cost-effectiveness of drug abuse prevention programs for high-risk youth -- Implications for prevention policy: a commentary.
General note	"Based on the papers from a technical review ... held on July 28-29, 1994"--P. ii.
Bibliography note	Includes bibliographical references.
Other forms	Also available via Internet from NIDA web site. Address as of 7/21/04: http://165.112.78.61/pdf/monographs/monograph176/download176.html; current access available via PURL.
LCCN	98186785
GPO item number	0831-C-12
GPO item number	0831-C-12 (online)
Govt. docs number	HE 20.3965:176

Availability

Library	Location	Call Number	Status	Item Actions
Joyner	Fed Docs Stacks	HE 20.3965:176	✔ Available	Place Hold

Cost-benefit/cost-effectiveness research of drug abuse prevention : implications for programming and policy / editors, William J. Bukoski, Richard I. Evans.

Click here for more information about this title

Availability